Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity
A major goal of the field of pharmacogenomics is to identify the genomic causes of serious adverse drug reactions (ADRs). Increasingly, genome-wide association studies (GWAS) have been used to achieve this goal. In this article, we review recent progress in the identification of genetic variants associated with ADRs using GWAS and discuss emerging themes from these studies. We also compare aspects of GWAS for ADRs to GWAS for common diseases. In the second part of the article, we review progress in performing pharmacogenomic research in multi-ethnic populations and discuss the challenges and opportunities of investigating genetic causes of ADRs in ethnically diverse patient populations..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Pharmacogenomics - 16(2015), 10, Seite 1161 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chan, Sze Ling [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
| doi: |
10.2217/PGS.15.54 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1960944282 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1960944282 | ||
| 003 | DE-627 | ||
| 005 | 20230513214301.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2217/PGS.15.54 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1960944282 | ||
| 035 | |a (DE-599)GBVOLC1960944282 | ||
| 035 | |a (PRQ)g1572-8347e8f59245305876f943c4a762e6b5082f1a885afd45bdb740c0a79409b3990 | ||
| 035 | |a (KEY)0406126820150000016001001161progressinunderstandingthegenomicbasisforadversedr | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Chan, Sze Ling |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a A major goal of the field of pharmacogenomics is to identify the genomic causes of serious adverse drug reactions (ADRs). Increasingly, genome-wide association studies (GWAS) have been used to achieve this goal. In this article, we review recent progress in the identification of genetic variants associated with ADRs using GWAS and discuss emerging themes from these studies. We also compare aspects of GWAS for ADRs to GWAS for common diseases. In the second part of the article, we review progress in performing pharmacogenomic research in multi-ethnic populations and discuss the challenges and opportunities of investigating genetic causes of ADRs in ethnically diverse patient populations. | ||
| 650 | 4 | |a Genomes | |
| 650 | 4 | |a Pharmacogenetics | |
| 700 | 1 | |a Jin, Shengnan |4 oth | |
| 700 | 1 | |a Loh, Marie |4 oth | |
| 700 | 1 | |a Brunham, Liam R |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d London : Future Medicine, 2000 |g 16(2015), 10, Seite 1161 |w (DE-627)320595625 |w (DE-600)2019513-8 |w (DE-576)364344261 |x 1462-2416 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2015 |g number:10 |g pages:1161 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.2217/PGS.15.54 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25978008 |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1711515731 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 16 |j 2015 |e 10 |h 1161 | ||